Legal status in the United States

Is Ipamorelin legal?

Read at FDA, DEA and WADAPublished by PepVault

Ipamorelin has no FDA-approved product, is not a federally controlled substance, and is banned in sport (WADA names it under S2.2.4), as of November 18, 2026.

Ipamorelin at a glance

CheckStatus, read Nov 18, 2026
FDA approvalNot approved
CompoundingOn FDA’s safety-risk list for outsourcing facilities (503B category 2)
DEA scheduleNot controlled
Sport (WADA)Banned, named (S2.2.4)

FDA approval

Ipamorelin has no FDA-approved product: Drugs@FDA lists no application for it.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

FDA keeps ipamorelin acetate in category 2 for outsourcing facilities (503B, since September 29, 2023): bulk substances that may raise significant safety risks. For pharmacies (503A) its nominations were withdrawn, and it is in none of the three 503A categories on FDA’s list updated May 14, 2026.

The source: “Compounded drugs containing Ipamorelin acetate may pose risk for immunogenicity”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

WADA bans ipamorelin at all times, in and out of competition: the 2026 list names it among the growth hormone secretagogues under S2.2.4.

The source: “ibutamoren (MK-677), ipamorelin”

How it is sold when it isn’t approved

FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

The source: falsely labeled “for research purposes” or “not for human consumption.”

What this means and doesn’t

This page reports what the agencies’ own pages said about Ipamorelin in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Ipamorelin FDA approved?

    Ipamorelin has no FDA-approved product: Drugs@FDA lists no application for it.

  • Is Ipamorelin a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Ipamorelin banned in sport?

    WADA bans ipamorelin at all times, in and out of competition: the 2026 list names it among the growth hormone secretagogues under S2.2.4.

  • What does FDA say about compounding Ipamorelin?

    FDA keeps ipamorelin acetate in category 2 for outsourcing facilities (503B, since September 29, 2023): bulk substances that may raise significant safety risks. For pharmacies (503A) its nominations were withdrawn, and it is in none of the three 503A categories on FDA’s list updated May 14, 2026.

  • What does FDA say about the “research use only” label?

    FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo